Company / Assets per Share
Spero Therapeutics, Inc. Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.26
FY2025
5-year range
$1.26 / $5.85
FY2021-FY2025
Trend
-39.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has declined for 5 consecutive years, from $8.00 in FY2020 to $1.26 in FY2025.
Based on SEC 10-K filings.
1.26 in FY2025 with a 5-year CAGR of -30.9%.
Declined from $3.48 to $1.26 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -31.1%
- 5-Year CAGR
- -30.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- Spero Therapeutics, Inc.'s assets per share has declined for 5 consecutive years.
- In FY2025, assets per share decreased 39.5% year-over-year.
- Peak assets per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.26 | -39.5% |
| FY2024 | $2.09 | -40.0% |
| FY2023 | $3.48 | -9.8% |
| FY2022 | $3.85 | -34.1% |
| FY2021 | $5.85 | -26.9% |
| FY2020 | $8.00 | +29.7% |
| FY2019 | $6.17 | -31.3% |
| FY2018 | $8.98 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026